Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Label-Free Detection Market worth $ 1,311.2 Million by 2022

 



(PharmaNewsWire.Com, April 24, 2019 ) The report "Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Thermodynamics, Lead Generation), End User - Global Forecast to 2022", The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.2 Million in 2017, at a CAGR of 8.5%. Innovations in label-free detection technologies, increasing drug discovery programs through research partnerships between pharmaceutical companies and academic institutes, and growth in the global pharmaceutical and biotechnology industries are factors driving the growth of this market. On the other hand, the high cost of instruments is likely to restrain the market growth to a certain extent.

Browse 110 Market Data Tables and 39 Figures spread through 147 Pages and in-depth TOC on "Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Thermodynamics, Lead Generation), End User - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/label-free-detection-market-32435593.html

Early buyers will receive 10% customization on reports.
Instruments are estimated to dominate the market in 2017
On the basis of product, the label-free detection market is segmented into instruments and consumables. The instruments segment is expected to dominate the global label-free detection market in 2017. Advantages of label-free detection technique in studying bio-molecular interactions and increasing inclination towards employing biosensor enabled detection of biomolecules in drug discovery and research are the key drivers for the growth of this segment.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=32435593

The surface plasmon resonance segment is estimated to command the largest market share in 2017
The label-free detection market is segmented by technology into surface plasmon resonance, bio-layer interferometry, isothermal titration calorimetry, differential scanning calorimetry, and other technologies. In 2017, the surface plasmon resonance is expected to account for the largest share of the label-free detection market, by technology. The large share of this segment can primarily be attributed to the increasing need for studying biomolecular interaction analysis in drug discovery processes and the increasing demand for biosensors in the digitalization of drug manufacturing processes.

North America expected to account for the largest share of the market in 2017
Based on region, the label-free detection market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the label-free detection market in 2017. The large share of North America is attributed to increasing drug discovery and development research activities and public and private funding for label-free detection in this region.

Submit here for Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=32435593

Key players in the label-free detection market include General Electric (US), Danaher (US), PerkinElmer (US), AMETEK (US), Roche (Switzerland), Corning (US), Hitachi (Japan), HORIBA (Japan), Shimadzu (Japan), TA Instruments. (US), Mettler-Toledo (US), Spectris (Malvern PANalytical) (UK), BiOptix (US), Wyatt Technology (UK), ACEA BIO (US), Attana (Sweden), NanoTemper Technologies (Germany), Affinité Instrument (Canada), Nicoya Lifesciences (Canada), Applied Photophysics (UK), Biosensing Instrument (US), Unchained Labs. (US), BioNavis (Finland), Insplorion (Sweden), and LUMICKS (Netherlands).


MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC